GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » IDL Diagnostics AB (OSTO:IDLDX) » Definitions » Capex-to-Operating-Cash-Flow

IDL Diagnostics AB (OSTO:IDLDX) Capex-to-Operating-Cash-Flow : 0.00 (As of Dec. 2024)


View and export this data going back to 2011. Start your Free Trial

What is IDL Diagnostics AB Capex-to-Operating-Cash-Flow?

Capex-to-Operating-Cash-Flow assesses how much of a company’s cash flow from operations is being devoted to capital expenditure. It’s also useful to distinguish whether the company is capital intensive or not.

IDL Diagnostics AB's Capital Expenditure for the three months ended in Dec. 2024 was kr0.00 Mil. Its Cash Flow from Operations for the three months ended in Dec. 2024 was kr3.25 Mil.

Hence, IDL Diagnostics AB's Capex-to-Operating-Cash-Flow for the three months ended in Dec. 2024 was 0.00.


IDL Diagnostics AB Capex-to-Operating-Cash-Flow Historical Data

The historical data trend for IDL Diagnostics AB's Capex-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IDL Diagnostics AB Capex-to-Operating-Cash-Flow Chart

IDL Diagnostics AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Capex-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

IDL Diagnostics AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Capex-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of IDL Diagnostics AB's Capex-to-Operating-Cash-Flow

For the Diagnostics & Research subindustry, IDL Diagnostics AB's Capex-to-Operating-Cash-Flow, along with its competitors' market caps and Capex-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IDL Diagnostics AB's Capex-to-Operating-Cash-Flow Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, IDL Diagnostics AB's Capex-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where IDL Diagnostics AB's Capex-to-Operating-Cash-Flow falls into.


;
;

IDL Diagnostics AB Capex-to-Operating-Cash-Flow Calculation

IDL Diagnostics AB's Capex-to-Operating-Cash-Flow for the fiscal year that ended in Dec. 2024 is calculated as

Capex-to-Operating-Cash-Flow=- Capital Expenditure / Cash Flow from Operations
=- (-0.581) / -2.358
=N/A

IDL Diagnostics AB's Capex-to-Operating-Cash-Flow for the quarter that ended in Dec. 2024 is calculated as

Capex-to-Operating-Cash-Flow=- Capital Expenditure / Cash Flow from Operations
=- (0) / 3.25
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


IDL Diagnostics AB  (OSTO:IDLDX) Capex-to-Operating-Cash-Flow Explanation

Capex-to-Operating-Cash-Flow ratio assesses how much of a company’s Cash Flow from Operations is being devoted to Capital Expenditure. It is a good indicator in terms of how much the company is focused on growth. In general, a high Capex-to-Operating-Cash-Flow ratio indicates that the company is investing more in physical assets and is focused on growth and expansion. Conversely, lower ratio could indicate that a company has reached maturity and is no longer pursuing aggressive growth.

Moreover, the ratio is also useful to distinguish whether the company is capital intensive or not. If the ratio is large, then the company tends to be capital intensive. Lower ratio suggests that it’s a capital-light business. The ratio can be combined with ROIC % to identify whether the company is an asset-light business that has a high return on invested capital. This is one question investors commonly ask to see if a company qualifies as a good company.


IDL Diagnostics AB Capex-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of IDL Diagnostics AB's Capex-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


IDL Diagnostics AB Business Description

Traded in Other Exchanges
Address
Karlsbodavagen 39, Bromma, Stockholm, SWE, 168 67
IDL Diagnostics AB is a Swedish company that develops and markets blood and urine sample tests. It specializes in oncology and bacteriology. The company has a broad product portfolio, is used in healthcare, and is established in various markets. In oncology, IDL Diagnostics uses various biomarkers, TK1 and cytokeratins, to support the treatment of cancers such as breast, prostate, and bladder cancers.

IDL Diagnostics AB Headlines

No Headlines